Proplex® vs. proplex® SX: A controlled double blind study of the effectiveness in treating acute hemarthroses in hemophilia a patients with inhibitors to factor VIII
- 1 June 1986
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 42 (6) , 789-796
- https://doi.org/10.1016/0049-3848(86)90115-5
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- The Effect of Activated Prothrombin-Complex Concentrate (FEIBA) on Joint and Muscle Bleeding in Patients with Hemophilia A and Antibodies to Factor VIIINew England Journal of Medicine, 1981
- Efficacy of Prothrombin-Complex Concentrates in Hemophiliacs with Antibodies to Factor VIIINew England Journal of Medicine, 1980
- Activated factor VII: presence in factor IX concentrates and persistence in the circulation after infusionBlood, 1979
- ACTIVATED FACTOR-VII - PRESENCE IN FACTOR-IX CONCENTRATES AND PERSISTENCE IN THE CIRCULATION AFTER INFUSION1979
- Use of Prothrombin Complex Concentrates in Hemophiliacs with Inhibitors: Clinical and Laboratory StudiesPediatrics, 1978
- Prothrombin Complex ConcentratesAmerican Journal of Diseases of Children, 1978
- Activated Prothrombin Concentrate for Patients with Factor VIII InhibitorsNew England Journal of Medicine, 1974